Dynavax Technologies Corporation news

   Watch this stock
Showing stories 1 - 5 of about 5   

Articles published

DVAX 17.10 0.00 (0.00%)
price chart
7 Small Cap Stocks Holding Low Debt Ratios And Positive Analyst Ratings
When analysts on average favor a company, it signals that a company is doing a variety of things right for itself, which we think warrants further investigation and analysis.
Related articles »  
People Moves: September 2012
Dynavax announced the appointment of Christine Larson to the position of vice president and chief financial officer, a newly created position.
Hepatitis C Drug Companies and All-Oral Treatment: A $20 Billion Market
My main reason for thinking a sustainable stock rebound is possible was because it's a top-ten holding of value-investing legend Seth Klarman, who owns a 9.2% stake in the company (10 million shares) at an average purchase price of $8 per share (30% ...
Related articles »  
5 Pharmaceutical Companies With PDUFA Dates In Q1/2013
In addition to NP101, NuPathe has two proprietary product candidates based on its LAD, or Long-Acting Delivery, biodegradable implant technology that allows delivery of therapeutic levels of medication over a period of months with a single dose. NP201 ...
Related articles »  
Interest Rates Going Nowhere, Home Depot CFO Says
Home Depot could issue another $2 billion in debt and still remain below its maximum desired leverage ratio, but Chief Financial Officer Carol Tome said interest rates won't be moving up from their near-historic lows anytime soon, so the company doesn ...